Dementia Family Caregiver Study
Launched by UNIVERSITY OF CALIFORNIA, IRVINE · May 15, 2021
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
The Dementia Family Caregiver Study is looking to help family members who care for loved ones with dementia, such as Alzheimer's disease. This study will last for three months and involves home visits from community health workers who will guide caregivers in using wearable technology, like a smartwatch and a smart ring, to monitor their stress levels and sleep patterns. Caregivers will learn stress reduction techniques, like mindful breathing, and receive compassionate support and education on how to care for their loved ones better. The goal is to improve caregivers' health and well-being, making it easier for them to provide care and enjoy their time with the person they are looking after.
To participate in this study, you must be a relative caring for someone with dementia who lives in the community. You should be between the ages of 65 and 74, willing to wear the monitoring devices, and identify as Korean, Vietnamese, Latino/Hispanic, or non-Hispanic White, speaking English, Spanish, Vietnamese, or Korean. Participants can expect supportive visits and practical advice to help them manage caregiving challenges. It's important to know that individuals with certain health conditions, such as cognitive impairments or serious illnesses, may not be eligible to join. This study aims to provide valuable support to underserved caregivers, helping to improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a relative of community dwelling person with dementia (i.e., Alzheimer's Disease or related dementias)
- • providing primary care for the person with dementia
- • willing to wear monitoring devices (a smartwatch during day time and a smartring during night time for 3 months
- • self-reporting ethnicity/race as Korean, Vietnamese, Latino/Hispanic, or non-Hispanic Whites with the following languages spoken in this study: English, Spanish, Vietnamese, or Korean.
- Exclusion Criteria:
- • cognitive impairment that precludes an individual from understanding the consent process and completing surveys (for those aged 65 or older as assessed by Mini-Cog)
- • chronic drug abuse
- • currently active cancer treatment
- • need hospice care
- • other significant health problems (i.e., having pacemaker, epilepsy or neurologic disorder) that exclude wearing a smartwatch and a smartring
About University Of California, Irvine
The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irvine, California, United States
Patients applied
Trial Officials
Jung-Ah Lee, PhD
Principal Investigator
Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials